L Lashnews Medical aesthetics sourcing from China
News Sourcing Guide

【Seoul, South】Amorepacific Holdings Partners with Hiel Corporation to Target Beauty and Medical Markets

Editor’s Note

**Editor’s Note:** Amorepacific Holdings and Hiel Corporation have announced a strategic partnership to develop next-generation integrated solutions combining dermatological science with aesthetic medical device technology, targeting both beauty and medical markets.

Amorepacific Holdings and Hiel Corporation Join Forces to Target Beauty and Medical Markets

Reporter: Han Si-eun
/ Article Approved: 2026-07-27 16:22:16

Development of Next-Generation Integrated Solutions Combining Dermatological Science and Aesthetic Medical Device Technology

[Social Value = Reporter Han Si-eun]

Amorepacific Holdings has made a strategic investment in Hiel Corporation, a specialized aesthetic medical device company, and will collaborate on beauty and medical business initiatives.

Amorepacific Holdings announced on the 27th that it has signed an investment agreement with Hiel Corporation to strengthen cooperation in the beauty and medical fields.

▲ Amorepacific Group headquarters exterior / Photo provided by Amorepacific Group

The two companies plan to collaborate across product planning, R&D, distribution, and marketing by linking Hiel Corporation’s aesthetic medical device development capabilities, joint research with medical professionals, and global KOL (Key Opinion Leader) network with Amorepacific’s dermatological science research and skincare technology.

As part of this agreement, Amorepacific Holdings has made a strategic investment in Hiel Corporation. Based on this, the company aims to strengthen its mid-to-long-term partnership.

The two companies will pursue the development and commercialization of skin-related products such as skin boosters, cosmeceuticals, and medical devices. They will also jointly develop post-procedure aftercare products, collaborate on distribution to hospitals and clinics, and conduct joint R&D and marketing of raw materials and ingredients.

In particular, they plan to combine Hiel Corporation’s medical professional network and expertise in the aesthetic market with Amorepacific’s skin research capabilities and brand competitiveness to develop integrated solutions that connect professional treatments with daily skincare.

“Amorepacific has introduced various beauty solutions based on dermatological science research and innovative technology,” said Lee Sang-mok, CEO of Amorepacific Holdings. “Through this collaboration, we will develop next-generation beauty solutions that integrate dermatological science and medical device technology, providing new customer experiences in the global beauty and medical markets.”
“This agreement is an important starting point for combining Hiel Corporation’s accumulated expertise in medical aesthetics with Amorepacific’s dermatological science research capabilities,” said Kim In-yong, CEO of Hiel Corporation. “Together, we will create next-generation beauty and medical solutions.”

Meanwhile, Hiel Corporation, founded in 2021, is a specialized aesthetic medical device company. Its flagship product, ‘HILO WAVE,’ has driven business expansion in South Korea, Japan, Indonesia, Vietnam, and other countries. The company is actively pursuing global partnerships and building clinical evidence.

Full article: View original |
⏰ Published on: July 27, 2026